Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Non-motor features of Parkinson disease

Schapira AHV, Chaudhuri KR, Jenner P.

Nat Rev Neurosci. 2017 Jul;18(7):435-450. doi: 10.1038/nrn.2017.62. Epub 2017 Jun 8.

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

Dashtipour K, Bhidayasiri R, Chen JJ, Jabbari B, Lew M, Torres-Russotto D.

J Clin Mov Disord. 2017 Jun 6;4:9. doi: 10.1186/s40734-017-0055-1. eCollection 2017.

[The Othello syndrome in Parkinson's disease: an example of a lesser-known delusion]

Potters EC, van Asseldonk JTH, Tilanus JJD.

Tijdschr Psychiatr. 2017;59(5):302-305.

PRO: General Anesthesia for Deep Brain Stimulator Insertion in Patients With Parkinson Disease

Venkatraghavan L, Sheshadri V.

J Neurosurg Anesthesiol. 2017 Jul;29(3):348-349. doi: 10.1097/01.ana.0000520879.70965.73.

Four Cases of Parkinson Disease Diagnosed During the Postpartum Period

Maltête D, Grangeon L, Le Goff F, Ozel G, Fetter D, Ahtoy P, Temgoua O, Rouillé A, Lefaucheur R.

Obstet Gynecol. 2017 Jul;130(1):203-206. doi: 10.1097/AOG.0000000000002066.

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort

Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K; PARS Investigators.

JAMA Neurol. 2017 Aug 1;74(8):933-940. doi: 10.1001/jamaneurol.2017.0985.

Pharmacological and Toxicological Profile of Harmane-β-Carboline Alkaloid: Friend or Foe

Khan H, Patel S, Kamal MA.

Curr Drug Metab. 2017;18(9):853-857. doi: 10.2174/1389200218666170607100947.

A novel function for glucocerebrosidase as a regulator of sterylglucoside metabolism

Akiyama H, Hirabayashi Y.

Biochim Biophys Acta Gen Subj. 2017 Oct;1861(10):2507-2514. doi: 10.1016/j.bbagen.2017.06.003. Epub 2017 Jun 6.

The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis

Mendoza-Santiesteban CE, Gabilondo I, Palma JA, Norcliffe-Kaufmann L, Kaufmann H.

Front Neurol. 2017 May 24;8:206. doi: 10.3389/fneur.2017.00206. eCollection 2017.

Noradrenergic Modulation of Cognition in Health and Disease

Borodovitsyna O, Flamini M, Chandler D.

Neural Plast. 2017;2017:6031478. doi: 10.1155/2017/6031478. Epub 2017 May 3.

Adaptive Deep Brain Stimulation for Movement Disorders: The Long Road to Clinical Therapy

Meidahl AC, Tinkhauser G, Herz DM, Cagnan H, Debarros J, Brown P.

Mov Disord. 2017 Jun;32(6):810-819. doi: 10.1002/mds.27022.

What Would Dr. James Parkinson Think Today? Tau and Other Imaging Possibilities in Parkinson's Disease

Vaillancourt DE.

Mov Disord. 2017 Jun;32(6):805-806. doi: 10.1002/mds.27075.

Meta-analysis: Association of Helicobacter pylori infection with Parkinson's diseases

Shen X, Yang H, Wu Y, Zhang D, Jiang H.

Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12398. Epub 2017 Jun 9.

No time like the present - two hundred years of Parkinson's disease

Combes R.

Altern Lab Anim. 2017 May;45(2):57-59. doi: 10.1177/026119291704500206.

A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans

Chernoff N, Hill DJ, Diggs DL, Faison BD, Francis BM, Lang JR, Larue MM, Le TT, Loftin KA, Lugo JN, Schmid JE, Winnik WM.

J Toxicol Environ Health B Crit Rev. 2017;20(4):1-47. doi: 10.1080/10937404.2017.1297592. Epub 2017 Jun 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias